Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Non-Small-Cell Lung × Exercise × Clear all

Phase

Status

Completed 3 Recruiting 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 30 Breast Neoplasms 16 Neoplasms 15 Fatigue 7 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Hematologic Neoplasms 3 Mixed Cancer 2 Lymphedema 2 Lung Neoplasms 2 Frailty 2 Weight Loss 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Incontinence 1 Stomach Neoplasms 1 Smoking 1 Sedentary Behavior 1 Sarcoma 1 Rehabilitation After Lung Cancer Surgery 1 Recurrence 1 Primary Dysautonomias 1 Postoperative Complications 1 Patient Compliance 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1

Interventions

Cisplatin 73 Carboplatin 70 Pemetrexed 60 Docetaxel 53 Erlotinib Hydrochloride 39 Gemcitabine 37 Paclitaxel 32 Gefitinib 32 Radiotherapy 30 Drug Therapy 27 icotinib 25 osimertinib 24 pembrolizumab 22 Nivolumab 22 Vinorelbine 21 Bevacizumab 20 camrelizumab 19 anlotinib 19 Radiosurgery 15 Endostatins 15 atezolizumab 14 apatinib 14 endostar protein 13 aumolertinib 13 durvalumab 12 sintilimab 11 Surgical Procedures, Operative 8 Immune Checkpoint Inhibitors 8 Blood Specimen Collection 8 Crizotinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03334071 2019-07-08

EMBRACE

University Hospital Southampton NHS Foundation Trust

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡